[Experiences with surfactant therapy of adult respiratory distress syndrome].
We report on 2 patients with ARDS, who underwent a therapy with surfactant. In both cases the underlying reason for the lung disease probably was a viral pneumonia. In both patients the gas exchange improved after tracheal instillation of surfactant. This improvement however was much less than we know it from therapy of the respiratory distress syndrome of the premature babies. Reasons for these differences in response to surfactant are discussed.
Buheitel
G
G
Klinik mit Poliklinik für Kinder und Jugendliche, Friedrich-Alexander-Universität, Erlangen, Nürnberg.
Scharf
J
J
Harms
D
D
D002675:Child, Preschool; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008297:Male; D010100:Oxygen / Q000097:blood; D011024:Pneumonia, Viral / Q000150:complications / Q000628:therapy; D011658:Pulmonary Fibrosis / Q000150:complications; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000097:blood / Q000628:therapy*
D011663:Pulmonary Surfactants; D010100:Oxygen
Erfahrungen mit der Surfactanttherapie des adulten Atemnotsyndroms (ARDS).